Pulse Biosciences Statistics
Total Valuation
PLSE has a market cap or net worth of $1.01 billion. The enterprise value is $905.35 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PLSE has 67.27 million shares outstanding. The number of shares has increased by 17.41% in one year.
| Current Share Class | 67.27M |
| Shares Outstanding | 67.27M |
| Shares Change (YoY) | +17.41% |
| Shares Change (QoQ) | +1.62% |
| Owned by Insiders (%) | 73.18% |
| Owned by Institutions (%) | 8.92% |
| Float | 17.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.66 |
| P/TBV Ratio | 9.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.88, with a Debt / Equity ratio of 0.08.
| Current Ratio | 11.88 |
| Quick Ratio | 11.74 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.31% and return on invested capital (ROIC) is -39.67%.
| Return on Equity (ROE) | -67.31% |
| Return on Assets (ROA) | -36.70% |
| Return on Invested Capital (ROIC) | -39.67% |
| Return on Capital Employed (ROCE) | -45.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$956,875 |
| Employee Count | 56 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +89.92% in the last 52 weeks. The beta is 1.88, so PLSE's price volatility has been higher than the market average.
| Beta (5Y) | 1.88 |
| 52-Week Price Change | +89.92% |
| 50-Day Moving Average | 18.49 |
| 200-Day Moving Average | 17.43 |
| Relative Strength Index (RSI) | 38.22 |
| Average Volume (20 Days) | 235,313 |
Short Selling Information
The latest short interest is 2.32 million, so 3.44% of the outstanding shares have been sold short.
| Short Interest | 2.32M |
| Short Previous Month | 2.26M |
| Short % of Shares Out | 3.44% |
| Short % of Float | 13.30% |
| Short Ratio (days to cover) | 21.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -56.26M |
| Pretax Income | -42.55M |
| Net Income | -53.59M |
| EBITDA | -55.08M |
| EBIT | -56.26M |
| Earnings Per Share (EPS) | -$0.92 |
Full Income StatementBalance Sheet
The company has $118.04 million in cash and $8.90 million in debt, giving a net cash position of $109.14 million or $1.62 per share.
| Cash & Cash Equivalents | 118.04M |
| Total Debt | 8.90M |
| Net Cash | 109.14M |
| Net Cash Per Share | $1.62 |
| Equity (Book Value) | 114.86M |
| Book Value Per Share | 1.74 |
| Working Capital | 109.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$36.34 million and capital expenditures -$125,000, giving a free cash flow of -$36.47 million.
| Operating Cash Flow | -36.34M |
| Capital Expenditures | -125,000 |
| Free Cash Flow | -36.47M |
| FCF Per Share | -$0.54 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |